SIGN UP
LOG IN
A
AKBA
Akebia Therapeut
2.26
0.57+33.73%After Hours: 2.240 -0.02 -0.89%19:59 03/14 EDT
OPEN/PREV CLOSE1.770/1.690
TODAY RANGE1.755-2.290
VOL13.25M
MARKET CAP493.09M
52 WEEK RANGE0.8000-2.480
AVG VOL (3M)2.56M
% TURNOVER6.07%
TURNOVER--
P/E (TTM)-6.8693
% RANGE31.66%
EPS(TTM)-0.3290
P/E(FORWARD)-6.4571
P/B-10.3338
BVPS-0.2187
DIVIDEND--
P/S3.172
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP454.40M
SHARES OUTSTANDING218.18M
NEXT EARNINGS05/07-05/12
FREE FLOAT201.06M
LOT SIZE1
EX-DIV DATE--
News
Press Releases
Financial Reports
Profile
Benzinga·17h ago
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga·20h ago
Semtech Posts Better-Than-Expected Earnings, Joins Rubrik, DocuSign, PagerDuty And Other Big Stocks Moving Higher On Friday
Press release·1d ago
Akebia Therapeutics, Inc. Form 10-K for the Year Ended December 31, 2024
Seeking Alpha·1d ago
Akebia slumps after Q4 earnings miss
Seeking Alpha·1d ago
Akebia GAAP EPS of -$0.10 misses by $0.02, revenue of $46.49M beats by $9.13M
Reuters·1d ago
AKEBIA THERAPEUTICS INC: QTRLY LOSS PER SHARE $0.10
Same Industry
Name/Symbol
Change%
Price
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
② More than 40M Downloads Globally : data based on Webull Technologies Limited's internal statistics as of July 14, 2023.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
② More than 40M Downloads Globally : data based on Webull Technologies Limited's internal statistics as of July 14, 2023.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.